PRF Technologies (PRFX) vs Redhill Biopharma (RDHL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Redhill Biopharma is the larger company by market cap ($5.1 million vs $3.0 million), about 1.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PRFX | RDHL |
|---|---|---|
| Share price | $0.8587 | $0.578 |
| Market cap | $3.00M | $5.14M |
| 1-day change | -2.16% | +21.94% |
| Forward P/E | — | 19.27 |
| EPS (TTM) | $-4.09 | $0.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.95 | $2.14 |
| 52-week low | $0.851 | $0.435 |
| Distance from 52-week high | -89.20% | -72.99% |
| Average volume | 294.15K | 2.05M |
| Shares outstanding | 3.50M | 8.89M |
| Employees | 6 | 13 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About PRF Technologies
PRFX stock →PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia.
Healthcare · Drug Manufacturers - Specialty & Generic · 6 employees
About Redhill Biopharma
RDHL stock →RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H.
Healthcare · Drug Manufacturers - Specialty & Generic · 13 employees
PRFX vs RDHL FAQ
Which is bigger, PRF Technologies or Redhill Biopharma?
Redhill Biopharma (RDHL) is larger, with a market capitalization of $5.14M compared with $3.00M for PRF Technologies (PRFX).
Are PRF Technologies and Redhill Biopharma in the same industry?
Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.